Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids

Circulation Research

Volumn 81, Issue 2, 1997, Pages 258-267

  Weintraub, Neal L ^a,c   Fang, Xiang ^b   Kaduce, Terry L ^b   Vanrollins, Mike ^a   Chatterjee, Papri ^a   Spector, Arthur A ^a,b  

^a Departments of Microbiology and Internal Medicine   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Acyl coenzyme A synthase; Arachidonic acid; Dihydroxyeicosatrienoic acid; Epoxyeicosatrienoic acid; Porcine coronary artery

Indexed keywords

ARACHIDONIC ACID; BRADYKININ; EPOXIDE; ICOSATRIENOIC ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0030878472     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.2.258     Document Type: Article

References (49)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Moncada S, Gryglewski R, Bunting S, Vane JR. An enyme isolated from arteries transforms prostaglandin endoperoxides into an unstable substance that inhibits platelet aggregation. Nature. 1976;263:663-665.
3. Beny J-L, Brunet PC. Neither nitric oxide nor nitroglycerin accounts for all the characteristics of endothelially mediated vasodilatation of pig coronary arteries. Blood Vessels. 1988;25:308-311.
4. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-decrived arachidonic acid metabolite in mammals. J Physiol (Lond). 1994;481:407-414.
5. Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 1994;113:1548-1553.
6. Lischke V, Busse R, Hecker M. Selective inhibition by barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br J Pharmacol. 1995;115:969-974.
7. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors, Circ Res. 1996;78:415-423.
8. Chen G, Cheung DW. Modulation of endothelium-dependenl hyperpolarization and relaxation to acetylcholine in rat mesenteric artery by cytochrome P450 enzyme activity. Circ Res. 1996;79:827-833.
9. Fitzpatrick FA, Murphy RC. Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of 'epoxygenase'-derived eicosanoids. Pharmacol Rev. 1988;40:229-241.
10. Capdevila JH, Falck JR, Estabrook RW. Cytochrome P450 and the arachidonate cascade. FASEB J. 1992;6:731-736.
11. Oliw EH, Bylund J, Herman C. Bisallylic hydroxylation and epoxidation of polyunsaturated fatty acids by cytochrome P450. Lipids. 1996;31:1003-1021.
12. Rosolowsky M, Falck JR, Willerson JT, Campbell WB. Synthesis of lipoxygenase and epoxygenuse products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res. 1990;66:608-621.
13. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 1993;264:H327-H335.
14. Rosolowsky M, Campbell WB. Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine artery endothelial cells. Biochim Biophys Acta. 1996;1299:267-277.
15. Gebremedhin D, Ma Y-H, Falck JR, Roman RJ, VanRollins M, Harder DR. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol. 1992;263:H519-H525.
16. +-channel activity. Am J Physiol. 1996;270:F822-F832.
17. Fulton D, Mahboubi K, McGiff JC, Quilley J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol. 1995;114:99-102.
18. Karara A, Wei S, Spady D, Swift L, Capdevila JH, Falck JR. Arachidonic acid epoxygenase: structural characteristics and quantification of epoxyeicosatrienoates in plasma. Biochem Biophys Res Commun. 1992;182:1320-1325.
19. Wu S, Moomaw CR, Tomer KB, Falck JR, Zeldin DC. Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in human heart. J Biol Chem. 1996;271:3460-3468.
20. Capdevila J, Pramanik B. Napoli JL, Manna S, Falck JR. Arachidonic acid epoxidation: epoxyeicosatrienoic acids are endogenous constituents of rat liver. Arch Biochem Biophys. 1984;231:511-517.
21. Karara A, Dishman E, Falck JR, Capdevila JH. Endogenous epoxyeicosatrienoyl-phospholipids. J Biol Chem. 1991;266:7561-7569.
22. Karara A, Dishman E, Jacobson H, Falck JR, Capdevila JH. Stereochemical analysis of the endogenous epoxyeicosatrienoic acids of human kidney cortex. FEBS Lett. 1990;268:227-230.
23. VanRollins M, Kaduce TL, Knapp HR, Spector AA. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J Lipid Res. 1993;34:1931-1942.
24. 2+ entry in human and bovine endothelial cells. J Physiol (Lond). 1995;482:259-274.
25. Catella F, Lawson JA, Fitzgerald DJ, Fitzgerald GA. Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. Proc Natl Acad Sci U S A. 1990;87:5893-5897.
26. VanRollins M, Kaduce TL, Fang X, Knapp HR, Spector AA. Arachidonic acid diols produced by cytochrome P-450 monooxysenases are incorporated into phospholipids of vascular endothelial cells. J Biol Chem. 1996;271:14001-14009.
27. Proctor KG, Falck JR, Capdevila J. Intestinal vasodilation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450 monooxygenase. Circ Res. 1987;60:50-59.
28. Carroll MA, Schwartzman M, Capdevila J, Falck JR, McGiff JC. Vasoactivity of arachidonic acid epoxides. Eur J Pharmacol. 1987;138:281-283.
29. Pfister SL, Falck JR, Campbell WB. Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. Am J Physiol. 1991;261:H843-H852.
30. Fang X, Kaduce TL, Weintraub NL, VanRollins M, Spector AA. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle. Circ Res. 1996;79:784-793.
31. Zhu Y, Brand Schieber E, McGiff JC, Balazy M. Identification of arachidonate P-450 metabolites in human platelet phospholipids. Hypertension. 1995;25:854-859.
32. Weintraub NL, Joshi SN, Branch CA, Stephenson AH, Sprague RS, Lonigro AJ. Relaxation of porcine coronary artery to bradykinin: role of arachidonic acid. Hypertension. 1994;23:976-981.
33. Lonigro AJ, Weintraub NL, Branch CA, Stephenson AH, McMurdo L, Sprague RS. Endothelium-dependent relaxation to arachidonic acid in porcine coronary artery: is there a fourth pathway? Pol J Pharmacol. 1994;46:567-577.
34. Weintraub NL, Stephenson AH, Sprague RS, McMurdo L, Lonigro AJ. Relationship of arachidonic acid release to porcine coronary artery relaxation. Hypertension. 1995;26:684-690.
35. Spector AA, Kaduce TL, Hoak JC, Fry GL. Utilization of arachidonic and linoleic acids by cultured human endothelial cells. J Clin Invest. 1981;68:1003-1011
36. Folch JM, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
37. Spector AA, Kuduce TL, Hoak JC, Czervionke RL. Arachidonic acid availability and prostacyclin production by cultured human endothelial cells. Arteriosclerosis. 1983;3:323-331.
38. Bell ME, Peterson RG, Eichherg J. Metabolism of phospholipids in peripheral nerve from rats with chronic streptozotocin-induced diabetes: increased turnover of phosphatidylinositol 4,5-bis phosphate. J Neurochem. 1982;39:192-200.
39. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799-C822.
40. Cowan CL, Cohen RA. Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and NO-independcnt responses. Am J Physiol. 1991:261:H830-H835.
41. Nagao T, Vanhoutte PM. Hyperpolarization as a mechanism for endothelium-dependent relaxations of the porcine coronary artery. J Physiol (Lond). 1992;445:355-367.
42. Tomoda H, Igarashi K, Omura S. Inhibition of acyl Co-A synthetase by triacsins. Biochim Biophys Acta. 1987;921:595-598.
43. Korchak HM, Kane LH, Rossi MW, Corkey BE. Long chain acyl coenzyme A and signaling in neutrophils. J Biol Chem. 1994;269:30281-30287.
44. Fang X, VanRollins M, Kaduce TL, Spector AA. Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells. J Lipid Res. 1995;36:1236-1246.
45. VanRollins M, Kochanek PK, Evans RW, Schiding JK, Nemoto EM. Optimization of epoxyeicosatrienoic acid syntheses to test their effects on cerebral blood flow in vivo. Biochim Biophys Acta. 1995;1256:263-274.
46. Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthesh SC. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol. 1990;259:H1171-H1177.
47. Fitzpatrick FA, Ennis MD, Baze ME, Wynalda MA, McGee JE, Liggett WF. Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids: influence of stereochemistry. J Biol Chem. 1986;261:15334-15338.
48. VanRollins M. Epoxygenase metaboliles of docosahexaenoic and eicosapentaenoic acids inhibit platelet aggregation at concentrations below those affecting thromboxane synthesis. J Pharmacol Exp Ther. 1995;274:798-804.
49. G nitroarginine/indomethacin-resistant relaxation in bovine and porcine coronary arteries. Br J Pharmacol. 1996;119:1177-1186.